Target intelligence / Profile preview

High mobility group nucleosomal binding domain 2 pseudogene 24 (HMGN2P24)

Target
HMGN2P24
Molecular classification
Pseudogene, Homologous to chromatin-binding proteins (specifically to HMGN2), Noncoding genomic DNA sequence
01

Overview

High mobility group nucleosomal binding domain 2 pseudogene 24 (HMGN2P24) is a nonfunctional DNA element in the human genome. It shows strong sequence homology to the protein-coding gene HMGN2, which encodes a chromatin-binding protein involved in chromatin structure and gene regulation, but HMGN2P24 itself cannot produce a protein. As a pseudogene, it may participate in genetic regulation at the RNA level, potentially serving as a competitor or decoy for regulatory molecules (such as microRNAs) or affecting the stability of related messenger RNAs, but no direct biological function or therapeutic relevance has been attributed to HMGN2P24 itself. It is not recognized as a therapeutic target, receptor, enzyme, or biomarker for disease or patient selection.

02

Mechanism of action

None (there are currently no drugs or interventions that target HMGN2P24)

03

Biological functions

No direct protein-based biological functionsPossible regulatory roles through RNA interactions (e.g., may serve as decoys for microRNAs, or affect gene expression via RNA-based mechanisms, but specific evidence for HMGN2P24 is unavailable)
04

Disease associations

None confirmed; some pseudogenes have regulatory functions affecting disease-related genes (e.g., cancer, diabetes, by altering expression of parent genes), but no specific data for HMGN2P24
05

Safety considerations

None (no known direct relevance to drug action or safety)

Beyond the preview

Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 24 (HMGN2P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 24 (HMGN2P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call